✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

EBOS Group Ltd

Common Name
EBOS Group
Country
Australia
Sector
Healthcare
Industry
Medical Distribution
Employees
5,200
Ticker
EBO
Exchange
NZX
Description
EBOS Group Limited is a leading Australasian marketer, wholesaler, and distributor of healthcare, medical, pharmaceutical, and animal care products. Operating across Australia, New Zealand, and Southe...

EBOS Group's GHG Emissions Data Preview

In 2026, EBOS Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, EBOS Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2026202520242023-2019
Total Scope 1
6,132a
3,343a
3,530a
Total Scope 2
Market-Based
N/A
15,311b
N/A
Location-Based
19,780a
18,257a
18,289a
Unspecified Calculation Method
N/AN/AN/A
Total Scope 3
N/AN/AN/A
Total Scope 1 Revenue Intensity (tCO2e/$M)
0.6605a
0.415a
0.4021a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=EBO&reporting_period=2026"

Verified Sources Behind EBOS Group’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. EBOS Group's Climate Report 2026
b. EBOS Group's Financial & Extra-Financial Disclosure 2025
c. EBOS Group's Sustainability Report 2022

Insights into EBOS Group's Operational Emissions

In 2026, the total operational greenhouse gas (GHG) emissions of EBOS Group amounted to 25,912 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2025, the total operational greenhouse gas (GHG) emissions of EBOS Group increased by 19.96%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

EBOS Group's Scope 1 Emissions Over Time

2022202320242025202602 k4 k6 k8 ktCO2e+303%+18%-5%+83%
  • Total Scope 1
  • Year-over-Year Change

What are EBOS Group's Scope 1 emissions?

In 2026, the total Scope 1 emissions of EBOS Group were 6,132 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2025), EBOS Group's Scope 1 emissions increased by 83.43%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are EBOS Group's Scope 2 emissions?

In 2026, EBOS Group reported Scope 2 greenhouse gas (GHG) emissions of 19,780 tCO₂e using the location-based method.a

Has EBOS Group reduced its Scope 2 emissions over time?

Since 2021, EBOS Group's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 56.98%, reflecting a rising long-term trend in Scope 2 emissions over time.ac

Compared to the previous year (2025), EBOS Group's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that EBOS Group's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does EBOS Group use for Scope 2 reporting?

In 2026, EBOS Group reported its Scope 2 emissions using the location-based method.a

EBOS Group's Scope 2 Emissions Over Time

20212022202320242025202605 k10 k15 k20 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into EBOS Group’s GHG Emissions Intensity Compared to Industry Peers

In 2026, EBOS Group reported Scope 1 greenhouse gas (GHG) emissions of 6,132 tCO₂e and total revenues of USD 9,284 millions. This translates into an emissions intensity of 0.66 tCO₂e per millions USD.a

EBOS Group's Scope 1 Emissions Intensity Compared to Peers

51002,00020,000500,000Scope 1 Emissions (tCO2e)202005,000100,0001,000,000Revenues (Millions of USD)NavamedicYear: 2024Scope 1: 17 tCO2eRevenue: $M 47Scope 1 Intensity: 0.35 tCO2e/$MMediosYear: 2025Scope 1: 1,284 tCO2eRevenue: $M 2,444Scope 1 Intensity: 0.53 tCO2e/$MExcelsior MedicalYear: 2024Scope 1: 42 tCO2eRevenue: $M 261Scope 1 Intensity: 0.16 tCO2e/$MArjoYear: 2025Scope 1: 20,172 tCO2eRevenue: $M 1,196Scope 1 Intensity: 16.87 tCO2e/$MAs OneYear: 2024Scope 1: 165 tCO2eRevenue: $M 685Scope 1 Intensity: 0.24 tCO2e/$MUnipharYear: 2025Scope 1: 2,745 tCO2eRevenue: $M 3,615Scope 1 Intensity: 0.76 tCO2e/$MGalenicaYear: 2025Scope 1: 4,854 tCO2eRevenue: $M 5,220Scope 1 Intensity: 0.93 tCO2e/$MSinopharm GroupYear: 2024Scope 1: 48,786 tCO2eRevenue: $M 80,095Scope 1 Intensity: 0.61 tCO2e/$MCardinal HealthYear: 2025Scope 1: 154,395 tCO2eRevenue: $M 222,567Scope 1 Intensity: 0.69 tCO2e/$MCencoraYear: 2025Scope 1: 189,955 tCO2eRevenue: $M 321,358Scope 1 Intensity: 0.59 tCO2e/$MMcKessonYear: 2025Scope 1: 72,223 tCO2eRevenue: $M 359,140Scope 1 Intensity: 0.20 tCO2e/$MHanmi ScienceYear: 2025Scope 1: 4,649 tCO2eRevenue: $M 940Scope 1 Intensity: 4.95 tCO2e/$MChina National MedicinesYear: 2024Scope 1: 907 tCO2eRevenue: $M 6,934Scope 1 Intensity: 0.13 tCO2e/$MAmplifonYear: 2025Scope 1: 7,259 tCO2eRevenue: $M 2,817Scope 1 Intensity: 2.58 tCO2e/$MAsker Healthcare GroupYear: 2025Scope 1: 4,978 tCO2eRevenue: $M 1,825Scope 1 Intensity: 2.73 tCO2e/$MHenry ScheinYear: 2024Scope 1: 33,555 tCO2eRevenue: $M 12,673Scope 1 Intensity: 2.65 tCO2e/$MSuzukenYear: 2024Scope 1: 26,205 tCO2eRevenue: $M 15,759Scope 1 Intensity: 1.66 tCO2e/$MAlfresa HoldingsYear: 2025Scope 1: 31,360 tCO2eRevenue: $M 19,746Scope 1 Intensity: 1.59 tCO2e/$MMedipal HoldingsYear: 2025Scope 1: 30,315 tCO2eRevenue: $M 24,481Scope 1 Intensity: 1.24 tCO2e/$MJointown Pharmaceutical GroupYear: 2024Scope 1: 36,924 tCO2eRevenue: $M 20,801Scope 1 Intensity: 1.78 tCO2e/$MBaiyunshan Pharmaceutical HoldingsYear: 2024Scope 1: 34,043 tCO2eRevenue: $M 10,276Scope 1 Intensity: 3.31 tCO2e/$MSigma HealthcareYear: 2024Scope 1: 8 tCO2eRevenue: $M 3,028Scope 1 Intensity: 0.00 tCO2e/$MEBOS GroupYear: 2026Scope 1: 6,132 tCO2eRevenue: $M 9,284Scope 1 Intensity: 0.66 tCO2e/$M

How does EBOS Group's GHG emissions intensity compare to its peers?

In 2026, EBOS Group reported a Scope 1 emissions intensity of 0.66 tCO₂e per millions USD. Compared to the peer group median of 0.84, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does EBOS Group rank on GHG emissions intensity within its industry?

In 2026, EBOS Group ranked 10 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

EBOS Group is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to EBOS Group's GHG Emissions Dataset?
Start 30-Day Free Trial